Neuromuscular Adverse Events Associated with Anti-PD-1 Monoclonal Antibodies
Neurol 92:663-674, Johansen, A.,et al, 2019
Inflammatory Myopathies with Anti-Ku Antibodies
Medicine 91:95-102, Rigolet,A.,et al, 2012
Polymyositis, Dermatomyositis, and Inclusion-Body Myositis
NEJM 325:1487-1498, Dalakas,M.C., 1991
Inflammatory Muscle Diseases
NEJM 372:1734-1747, Dalakas, M.C., 2015
CIDP:Clinical Features & Responses to Trtm in 67 Consecutive Pts with/without a Monoclonal Gammopathy
Neurol 48:321-328, Gorson,K.G.,et al, 1997
Inclusion Body Myositis, Observations in 40 Patients
Brain 112:727-747, Lotz,B.P.,et al, 1989
Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Clin Characteristics, Course, & Diag Criteria
Arch Neurol 46:878-884, Barohn,R.J.,et al, 1989
Necrotizing Myopathy Associated with Steroid Therapy, Report of Two Cases
Pathology 14:435-438, Ojeda,V.J., 1982
Eosinophilic Polymyositis
Arch Neurol 36:721-722, 1979, Stark,R.J., 1979
Eosinophilic Polymyositis
Ann Neurol 1:65, Layzer,R.B.,et al, 1977
Case Records of the MassGeneral Hospital, Case 41-1975, Acute Intermittent Porphyria
NEJM 293:817, Woods,B., 1975
Five Types of Dystrophy
Together with Other Conditions Producing Insidious Muscle Weakness-Table 1-Hospital Med p. 60., , 1850